AI for R&D: Episode 4 | Positively disrupting pharmaceutical R&D with AI/ML

Nathan Sommerford, Global Lead of AI for Drug Discovery & Development at IQVIA, discusses how AI/ML is disrupting R&D across the board.  In this episode: How working in synergy with clinicians and research scientists, AI/ML can provide a much-needed augmentation to how drugs are developed.  Understand where to apply AI, whether it's early in drug discovery, to find the right patient subpopulations or to do disease modeling.  Explore using a machine learning approach based on fairness ranking systems to best represent a clinical trial patient base and address the challenge of diversity and inclusion.